01-chemical-structure (01 Chemical Structure)
Formoterol Fumarate Inhalation Solution
Product Images NDC 76204-030
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate Inhalation Solution (NDC 76204-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
04-image-01 (04 Image 01)
05-image-02 (05 Image 02)
06-image-03 (06 Image 03)
08-formoterol-60ct (08 Formoterol 60ct)
This text provides information about the storage conditions, usage instructions, and details of Formoterol Fumarate Inhalation Solution. It includes guidance for healthcare providers and patients regarding storage temperature, expiry dates, and proper handling of the medication. The text also mentions the manufacturer and National Drug Code for the product.*
Formoterol-30ct (Formoterol 30ct)
This text provides detailed storage and usage instructions for the medication Formoterol Fumarate Inhalation Solution. It includes information on storage conditions both before and after dispensing to the patient, emphasizing the importance of protecting the product from light and heat. The text also mentions the "Use by" date and advises discarding the product if expired. Additionally, it specifies that the vial should always be stored in the foil pouch and only removed immediately before use. The product is indicated for oral inhalation only and comes in sterile unit dose vials. The text also mentions specific temperature ranges for storage and mentions the product expiration timeframe.*
Mean-fev1-12weeks (Mean Fev1 12weeks)
This text provides information on the Mean FEV in Liters after a 12-week treatment with Formoterol Fumarate Inhalation Solution and Placebo. The data includes the Mean FEV values at the endpoint for each treatment group. The study involved 129 participants in the Formoterol Fumarate Inhalation Solution group and 114 in the Placebo group.*
Mean-fev1-day1 (Mean Fev1 Day1)
This text provides data on mean Forced Expiratory Volume (FEV) in Liters for different conditions. The values range from 110 to 180. The data seems related to a study or experiment comparing Formoterol Fumarate Inhalation Solution with a placebo on 114 participants. The figure presents information on mean FEV at Day 1.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
